Ramesh Krishnan

"We are keen to have a large facility in the NCR region, which is missing in our current city network in the country and our key focus under the Gleneagles brand will remain complex transplant surgeries, including liver, heart, bone marrow among others. This will create a niche for us in this market, but at the same time, we will continue to have a strategy to cater to the needs of the particular location where we are present. So acquiring existing hospitals assets, which has already established itself in that market understanding the local needs, would always be our preferred targets for acquisition."

Ramesh Krishnan,
Chief Executive Officer, India Operations,
Parkway Pantai

Parkway Pantai, which recently pulled out from the discussions with Fortis Healthcare for acquiring the latter's hospitals and diagnostic arm in India, is still looking for acquiring large hospital assets in the country, especially in the national capital region (NCR), as part of its pan India expansion.

The multinational hospital group that is part of the world's second largest healthcare group IHH Healthcare is keen to make its mark in the country by setting up an extensive complex organ transplant chain, which is the strength of its globally renowned Gleneagles brand.

Having entered the Indian market in 2015 by acquiring Hyderabad-based Continental Hospitals and another tertiary care chain Global Hospitals, Parkway Pantai has already integrated Global Hospital chain with its global brand Gleneagles. Currently, it has key healthcare facilities in Hyderabad, Chennai, Bengaluru, and Mumbai.India is currently Parkway's third biggest market after Malaysia and Singapore, with at least 10 hospitals in the country following the first two acquisitions. In March 2015, Parkway bought a 51 percent stake in Continental Hospitals for some 300 crore. Immediately after this deal, the Singapore-based group also bought 74 percent equity in Global Hospitals for 1800 crore.


Digital version